PURPOSE: Using the autofluorescent properties of 5-aminosalicylic acid (5-ASA), we studied the penetration and distribution of this molecule in human colonic biopsies at different time intervals after administration of 5-ASA enemas. METHODS: Fluorescence scores of rectosigmoidal biopsy specimens were compared with 5-ASA and acetyl-5-aminosalicylic (Ac-S-ASA) concentrations, determined by high-performance liquid chromatography, in adjacent biopsies and in serum samples. RESULTS: 5-ASA penetrates into the rectal mucosa and into the epithelial cells after local application by means of an enema. We found a characteristic 5-ASA staining of two intramucosal structures that need further identification: intraepithelial triangular configurations and...
: Plasma levels of total 5-aminosalicylic acid (5-ASA) were determined after a single administration...
Background: Oral 5-aminosalicylic acid (5-ASA, mesalazine) is the first choice therapeutic agent for...
Background 5‐aminosalicylic acid (5‐ASA) is the first‐line therapy for ulcerative colitis (UC). 5‐A...
PURPOSE: Using the autofluorescent properties of 5-aminosalicylic acid (5-ASA), we studied the penet...
Following oral administration of sulphasalazine, 5-aminosalicylic acid (5-ASA) is present in serum a...
Following oral administration of sulphasalazine, 5-aminosalicylic acid (5-ASA) is present in serum a...
Intramucosal 5-aminosalicyclic acid (5-ASA) and acetylated 5-ASA (Ac-5-ASA) concentrations were dete...
AIM: To compare the mucosal concentrations of 5-aminosalicylic acid (5-ASA) resulting from different...
5-aminosalicylic acid (5-ASA) is a new treatment for patients suffering from ulcerative colitis but ...
5-aminosalicylic acid (5-ASA) is a new treatment for patients suffering from ulcerative colitis but ...
OBJECTIVE: Recurrence of Crohn's disease quite inevitably occurs after resection of distal small bow...
Isolated human colonic epithelial cell suspensions were incubated with either 0.1 mM 5-aminosalicyli...
OBJECTIVE: Recurrence of Crohn's disease quite inevitably occurs after resection of distal small bow...
Isolated human colonic epithelial cell suspensions were incubated with either 0.1 mM 5-aminosalicyli...
: Plasma levels of total 5-aminosalicylic acid (5-ASA) were determined after a single administration...
: Plasma levels of total 5-aminosalicylic acid (5-ASA) were determined after a single administration...
Background: Oral 5-aminosalicylic acid (5-ASA, mesalazine) is the first choice therapeutic agent for...
Background 5‐aminosalicylic acid (5‐ASA) is the first‐line therapy for ulcerative colitis (UC). 5‐A...
PURPOSE: Using the autofluorescent properties of 5-aminosalicylic acid (5-ASA), we studied the penet...
Following oral administration of sulphasalazine, 5-aminosalicylic acid (5-ASA) is present in serum a...
Following oral administration of sulphasalazine, 5-aminosalicylic acid (5-ASA) is present in serum a...
Intramucosal 5-aminosalicyclic acid (5-ASA) and acetylated 5-ASA (Ac-5-ASA) concentrations were dete...
AIM: To compare the mucosal concentrations of 5-aminosalicylic acid (5-ASA) resulting from different...
5-aminosalicylic acid (5-ASA) is a new treatment for patients suffering from ulcerative colitis but ...
5-aminosalicylic acid (5-ASA) is a new treatment for patients suffering from ulcerative colitis but ...
OBJECTIVE: Recurrence of Crohn's disease quite inevitably occurs after resection of distal small bow...
Isolated human colonic epithelial cell suspensions were incubated with either 0.1 mM 5-aminosalicyli...
OBJECTIVE: Recurrence of Crohn's disease quite inevitably occurs after resection of distal small bow...
Isolated human colonic epithelial cell suspensions were incubated with either 0.1 mM 5-aminosalicyli...
: Plasma levels of total 5-aminosalicylic acid (5-ASA) were determined after a single administration...
: Plasma levels of total 5-aminosalicylic acid (5-ASA) were determined after a single administration...
Background: Oral 5-aminosalicylic acid (5-ASA, mesalazine) is the first choice therapeutic agent for...
Background 5‐aminosalicylic acid (5‐ASA) is the first‐line therapy for ulcerative colitis (UC). 5‐A...